Resurgent Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Resurgent Financial Advisors's PFE Position: Q2 2026 in Review
Resurgent Financial Advisors increased its Pfizer (PFE) stake by 3.1% in Q2 2026, buying an estimated $41.1K and bringing the position to 52,559 shares worth $1.27M. The position accounts for 0.35% of the portfolio, ranked #63.
Resurgent Financial Advisors first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.5M in Q2 2022. 2,828 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Resurgent Financial Advisors held 52,559 shares of Pfizer worth $1.27M as of Q2 2026.
- Resurgent Financial Advisors bought 1,572 Pfizer shares in Q2 2026, an estimated $41.1K.
- Pfizer made up 0.35% of Resurgent Financial Advisors's portfolio in Q2 2026, its #63 holding.
- Resurgent Financial Advisors first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Resurgent Financial Advisors's Pfizer position peaked at $2.5M in Q2 2022.
- 2,828 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Resurgent Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.